Altamira Therapeutics Ltd.: xbrl:AdditionsToRightofuseAssets

Value{"unit": "CHF", "value": 594436}
Period2021-01-01 – 2021-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-23-040152
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/ce8fb007-2067-49e5-be46-1e68e0817437

History